
Rula Geha, MD
Clinician, NOHO
Rula Geha, MD
Clinician, NOHODr. Rula C. Geha, MD, is a physician and life sciences executive with nearly two decades of clinical experience, specializing in oncology across inpatient and outpatient settings. She serves as Vice President of Life Sciences and Senior Medical Director of Corporate Health at MacAndrews and Forbes, where she leads corporate health strategy, conducts due diligence on emerging therapeutics and biotechnologies, and oversees philanthropic medical initiatives for the company’s 100 million dollar foundation. She has built high-impact clinical programs, including launching an in-house medical clinic and developing custom medical record and inventory systems.
Dr. Geha completed fellowships in surgical oncology and endocrine surgery at the Hospital of the University of Pennsylvania and Montefiore Medical Center. She previously practiced as an attending surgeon at Montefiore and Crystal Run Healthcare, performing complex procedures and conducting research in neuroendocrine, endocrine, and ovarian cancers. She earned her MD from Case Western Reserve University, completed residency at Columbia Presbyterian, and holds degrees in molecular biology and biochemistry from Wesleyan University.
- Undergraduate: BA/BS in Molecular Biology and Biochemistry from Wesleyan University
- Medical school: MD from Case Western Reserve University School of Medicine
- Residency: General Surgery at Columbia Presbyterian (Columbia University Medical Center)
- Fellowships: Surgical Oncology at the Hospital of the University of Pennsylvania; Endocrine Surgery at Montefiore Medical Center
- Surgical Oncology
- Breast Oncology
- Corporate Health Strategy
- Health Economics & Outcomes Research

“Outcomes After Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients.”De La Cruz L, Blankenship SA, Chatterjee A, Geha R, Nocera N, Czerniecki BJ, Tchou J, Fisher CS | Oct 2016, Ann Surg Oncol. 23(10):3247-58
“A cost-effective handheld breast scanner for use in low-resource environments: a validation study”Broach RB, Geha RC, Englander BS, DeLaCruz L, Thrash H, Brooks AD | Oct 28, 2016, World J Surg Oncol. 14(1):277
“Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature”Datta J, Ecker BL, Neuwirth MG, Geha RC, Fraker DL, Roses RE, Karakousis GC | Jun 2017, Surg Oncol. 26(2):117-124
“A Single Institution’s Randomized Double Armed Prospective Study of Lumpectomy Margins with Adjunctive Use of the MarginProbe in Nonpalpable Breast Cancers.”Geha RC, Taback BT, Feldman S | Aug 9, 2020, The Breast J.
- Cushings Syndrome Book Chapter 2018Geha RC, Libutti SK | 2018, Textbook of Complex General Surgical Oncology (eds. Balch and Morita), Book Chapter
- End-Tidal CO2 Pulmonary Embolism Poster 2003Geha RC, Fleischer B, Chenitz K, Aranoff S, Widmann W | Jan 2003, Poster — 32nd Society of Critical Care Medicine, San Antonio, TX
- Water Suppression without Signal Loss HR-MAS NMR Cells TissuesSinger S, DeCarolis P, O'Connor R, Sambol EB, Geha RC, Chen JH | Feb 2005, Poster — Keystone Symposia: Frontiers of NMR in Molecular Biology IX, Banff, Alberta, Canada
- Flavopiridol Superior Imatinib Mesylate Gleevac GISTSambol EB, Kennealey PT, Motwani M, Geha RC, DeCarolis P, O'Connor R, Chen JH, Schwartz GK, Singer S | Feb 2005, Oral Presentation — Society of University Surgeons 66th Annual Meeting, Nashville, TN
- Support Vector Machine SVM NMR Liposarcoma SubtypesGeha RC, Eisenbud D, Sambol EB, Kennealey PT, DeCarolis P, Sander C, Chen JH, Singer S | Mar 2005, Oral Presentation — Society of Surgical Oncology 58th Annual Cancer Symposium, Atlanta, GA
- Water Interaction Membrane Phospholipid Protein Proton HR-MAS NMRChen JH, DeCarolis P, O'Connor R, Sambol EB, Geha RC, Singer S | May 2005, Poster — 13th ISMRM, Miami, FL
- NMR Detectable Cholesterol Early Marker Tumor Response Cytotoxic ChemotherapyKennealey PT, Sambol EB, DeCarolis P, Geha RC, She Y, Schwartz GK, Chen JH, Singer S | Oct 2005, Oral Presentation — 91st Clinical Congress American College of Surgeons, San Francisco, CA
- Flavopiridol Targets KIT Transcription and Induces Apoptosis in Gastrointestinal Stromal Tumor CellsSambol EB, Ambrosini G, Geha RC, Kennealey PT, DeCarolis P, O'Connor R, Motwani M, Chen JH, Schwartz GK, Singer S | Jun 1, 2006, Cancer Res. 66(11):5858-66
- Aprotinin Safety and Patient Selection Cardiovascular Surgical ProceduresGeha RC, Sternberg R | Apr 2007, Prepared for Cedars-Sinai Health System, Zynx Health, Los Angeles, CA
- Restoration of C/EBPa in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosisWu YV, Okada T, DeCarolis P, Socci N, O'Connor R, Geha RC, Joy Somberg C, Antonescu C, Singer S | Apr 2012, Genes Chromosomes Cancer. 51(4):313-27
- Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-alpha leads to synergistic antitumor activityYuan Z, Syrkin G, Adem A, Geha RC, Pastoriza J, Vrikshajanani C, Smith T, Quinn TJ, Alemu G, Cho H, Barrett CJ, Arap W, Pasqualini R, Libutti SK | Nov 16, 2012, Cancer Gene Ther.
- Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesisYuan Z, Syrkin G, Adem A, Geha RC, Pastoriza J, Vrikshajanani C, Smith T, Quinn TJ, Alemu G, Cho H, Barrett CJ, Arap W, Pasqualini R, Libutti SK | Mar 15, 2016, Oncotarget. 7(11):12633-50
- End-Tidal CO2 Pulmonary Embolism Oral 2002Geha RC, Fleischer B, Chenitz K, Aranoff S, Widmann W | Sep 2002, Oral Presentation — NJ Chapter of Critical Care Medicine Conference, New Brunswick, NJ
- Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococcusMayer R, Geha RC, Helfand MS, Hoyan CK, Salata RA, Donskey CD | Jun 2003, American Journal of Infection Control. 31(4):221-5
- Direct Observation of Membrane Lipid HydrationChen JH, DeCarolis P, O'Connor R, Sambol EB, Geha RC, Singer S | Feb 2005, Oral Presentation — Keystone Symposia: Frontiers of NMR in Molecular Biology IX, Banff, Alberta, Canada
- Flavopiridol Monotherapy Antiproliferative Soft Tissue SarcomaSambol EB, Kennealey PT, Motwani M, She Y, Geha RC, O'Connor R, Schwartz G, Singer S | Mar 2005, Oral Presentation — Society of Surgical Oncology 58th Annual Cancer Symposium, Atlanta, GA
- Flavopiridol active agent GIST imatinib mesylate resistanceSambol EB, Motwani M, Ambrosini G, Geha RC, DeCarolis P, O'Connor R, Chen JH, Schwartz GK, Singer S | Apr 2005, Poster — American Association of Cancer Research 96th Annual Meeting, Anaheim, CA
- Liposarcoma Subtyping Support Vector Machine HR-MAS NMRSinger S, Eisenbud D, O'Connor R, DeCarolis P, Geha RC, Sambol EB, Sander C, Chen JH | May 2005, Poster — 13th ISMRM, Miami, FL
- High-Resolution MAS NMR Spectroscopy Detection of the Spin Magnetization Exchange by Cross-Relaxation and Chemical Exchange in Intact Cell lines and Human Tissue SpecimensChen JH, Sambol EB, DeCarolis P, O'Connor R, Geha RC, Singer S | Jun 2006, Magn Reson Med. 55(6):1246-56
- Ribonucleotide Reductase M2 Subunit Novel Therapeutic Target LiposarcomaGeha RC, Wu W, Sambol EB, DeCarolis P, O'Connor R, Schwartz GK, Singer S | 2006, Oral Presentation — 92nd Clinical Congress of the American College of Surgeons, Chicago, IL
- Laparoscopic radical cholecystectomyGumbs AA, Milone L, Geha RC, Delacroix J, Chabot JA | 2009, J Laparoendosc Adv Surg Tech A
- Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse modelQuinn TJ, Yuan Z, Adem A, Geha RC, Vrikshajanani C, Koba W, Fine E, Hughes DT, Schmid HA, Libutti SK | Dec 2012, Surgery. 152(6):1068-77
- MarginProbe Poster 2015Geha RC, Taback BT, Feldman S | Apr 2015, Poster — American Society of Breast Surgeons 16th Annual Meeting, Orlando, FL
- A Cost-Effective Handheld Breast Scanner Poster 2016Geha RC, Broach R, De La Cruz L, Thrash H, Campisi M, Englander B, Shah M, Brooks AD | Apr 2016, Poster — American Society of Breast Surgeons 17th Annual Meeting, Dallas, TX